Finch Therapeutics Group
-$0.27 (-2.09%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell FNCH and other stocks, options, and ETFs commission-free!
About FNCH
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms.
CEO
Mark Smith
Employees
131,000
Headquarters
Somerville, Massachusetts
Founded
2017
FNCH Key Statistics
Market Cap
619.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
53.31K
High Today
$13.63
Low Today
$12.50
Open Price
$13.00
Volume
59.18K
52 Week High
$22.50
52 Week Low
$12.50
FNCH Earnings
Q1 FY21
Estimated
— per share
Actual
Expected May 18, Pre-Market